Clinical Trials Browser

NIH × Leukemia, Lymphocytic, Chronic, B-Cell × In Situ Hybridization, Fluorescence × Clear all

NCT00458523 2013-08-12

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell